Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Zuo H et al. | 2020 | intact cell/cell culture, PC12 (rat pheochromocytoma cells) | magnetic field, 50/60 Hz | 100 µT |
Cios A et al. | 2021 | intact cell/cell culture, HEK293 (kidney cells), 786-O, 769-P, and Caki1 (clear cell renal carcinoma cell lines) | magnetic field, 50/60 Hz | 4.5 mT |
Choi JH et al. | 2022 | intact cell/cell culture, human hair bulb spheroid and hair follicle cultures | magnetic field, 50/60 Hz | - |
Lazzarini R et al. | 2023 | intact cell/cell culture, MDA-MB-231 cells (breast cancer cell line) and MDA-MB-231 (human breast cell line) | magnetic field, 50/60 Hz | - |
Cichorowski R et al. | 2024 | intact cell/cell culture, HeLa GFP H2B cells | magnetic field, 50/60 Hz | - |
Wydorski PJ et al. | 2024 | tissue slices, endometrium, pig (<i>Sus scrofa Domestica</i> L., Polish Landrace×Great White Polish) | magnetic field, 50/60 Hz | - |
Saha S et al. | 2014 | animal, mouse/C57BL/6, whole body: <i>in utero</i> | magnetic field, 50/60 Hz, also other exposures without EMF | 100–300 µT |
Li Y et al. | 2019 | intact cell/cell culture, K562 cells (human erythroleukemic cell line) | magnetic field, 50/60 Hz, also other exposures without EMF | - |
Ramazi S et al. | 2023 | intact cell/cell culture, MCF-7 (human breast cancer cell line) and HFF cells (human foreskin fibroblast cells) | magnetic field, 50/60 Hz, also other exposures without EMF, co-exposure | - |
Watson JM et al. | 1998 | intact cell/cell culture, human endometrial stromal fibroblasts (primary cells and ESF-I (N5) cell line) and 12 endometrial, ovarian, and prostate cancer cell lines and immortazized human ovarian epithelial cells (OV-I) | magnetic field, 50/60 Hz, co-exposure | 200 µT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.